Hematuria differential diagnosis
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin, porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
CATEGORY[1] | EXAMPLES | COMMON CLINICAL PRESENTATION AND RISK FACTORS |
Neoplasm
|
Any
|
Male gender, Age older than 35 years, Past or current smoking history, Occupational or other exposure to chemicals or dyes (benzenes or aromatic amines), Analgesic abuse, History of gross hematuria, History of urologic disorder or disease, History of Irritative voiding symptoms, History of pelvic irradiation, History of chronic urinary tract infection, Exposure to known carcinogenic agents or chemotherapy such as alkylating agents, History of chronic indwelling foreign body |
Bladder cancer
|
Older age, male predominance, tobacco, occupational exposures, Irritative voiding symptoms | |
Ureteral or renal pelvis cancer
|
Family history of early colon cancers or upper tract tumors, flank pain | |
Renal cortical tumor
|
Family history of early kidney tumors, flank pain, flank mass | |
Prostate cancer
|
Older age, family history, African-American | |
Urethral cancer
|
Obstructive symptoms, pain, bloody discharge | |
Infection/inflammation
|
Any
|
History of infection |
Cystitis
|
Female predominance, dysuria | |
Pyelonephritis
|
Fever, flank pain, diabetes, female predominance | |
Urethritis
|
Exposure to sexually transmitted infections, urethral discharge, dysuria | |
Tuberculosis
|
Travel to endemic areas | |
Schistosomiasis
|
Travel to endemic areas | |
Calculus
|
Nephroureterolithiasis
|
Flank pain, family history, prior stone |
Bladder stones
|
Bladder outlet obstruction | |
Prostatic cause
|
Benign prostatic enlargement
|
Male, older age, obstructive symptoms |
Medical renal disease
|
Any
|
Hypertension, azotemia, dysmorphic erythrocytes, cellular casts, proteinuria |
IgA nephropathy
|
Upper respiratory tract infection, gastroenteritis, synchronous association of pharyngitis, children | |
Congenital or acquired anatomic abnormality
|
Polycystic kidney disease | Family history of renal cystic disease |
Uretero-pelvic junction obstruction | History of UTI, stone, flank pain | |
Ureteral stricture | History of surgery or radiation, flank pain, hydronephrosis; stranguria, spraying urine | |
Urethral diverticulum | Discharge, dribbling, dyspareunia, history of UTI, female predominance | |
Fistula | Pneumaturia, Fecaluria, abdominal pain, recurrent UTI, history of diverticulitis or colon cancer | |
Other
|
Exercise-induced hematuria
|
Recent vigorous exercise |
Endometriosis
|
Cyclic hematuria in a menstruating woman | |
Hematologic or thrombotic disease
|
Family history of personal history of bleeding or thrombosis | |
Papillary necrosis
|
African-American, sickle cell disease, diabetes, analgesic abuse | |
Interstitial cystitis
|
Voiding symptoms |
Differentiating Hemoglobinuria from Myoglobinuria
Centrifuse Result | |||||||||||||||||||||||||||||||||||||||||||
Sediment Red | Supernatant Red | ||||||||||||||||||||||||||||||||||||||||||
Hematuria | Dipstick heme | ||||||||||||||||||||||||||||||||||||||||||
Negative | Positive | ||||||||||||||||||||||||||||||||||||||||||
❑ Beeturia ❑ Phenazopyridine ❑ Porphyria ❑ Other | ❑ Myoglobin ❑ Hemoglobin | ||||||||||||||||||||||||||||||||||||||||||
Plasma color | |||||||||||||||||||||||||||||||||||||||||||
Clear | Red | ||||||||||||||||||||||||||||||||||||||||||
Myoglobinuria | Hemoglobinuria | ||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Wein, Alan (2016). Campbell-Walsh urology. Philadelphia, PA: Elsevier. ISBN 978-1455775675.